Avanos Medical
AVNS
299 hedge funds and large institutions have $1.42B invested in Avanos Medical in 2022 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 97 increasing their positions, 70 reducing their positions, and 32 closing their positions.
11,217% more call options, than puts
Call options by funds: $679K | Put options by funds: $6K
39% more repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 70
22% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 32
1.86% more ownership
Funds ownership: 91.06% → 92.93% (+1.9%)
1% more funds holding
Funds holding: 297 → 299 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less capital invested
Capital invested by funds: $1.52B → $1.42B (-$98M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$12.7M |
| 2 |
Millennium Management
New York
|
+$12.2M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$8.73M |
| 4 |
Morgan Stanley
New York
|
+$7.6M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$7.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$40.7M |
| 2 |
PIM
Paradice Investment Management
Denver,
Colorado
|
-$22.5M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$19.5M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$5.9M |
| 5 |
SG Americas Securities
New York
|
-$4.59M |
AVNS Hedge Fund Activity: Q1 2022 in Review
299 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q1 2022, worth a combined $1.42B — down 6.4% from $1.52B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new AVNS positions and 32 closed out — a net gain of 7 holders — while 97 added to existing stakes and 70 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $12.7M. The largest seller was Champlain Investment Partners, exiting entirely with an estimated $40.7M sold.
- 299 institutional investors held Avanos Medical (AVNS) as of Q1 2022, up from 297 in Q4 2021.
- Funds reported $1.42B of Avanos Medical stock for Q1 2022, down 6.4% quarter-over-quarter.
- 39 funds opened new Avanos Medical positions in Q1 2022 and 32 closed out, a net change of +7 holders.
- The largest Avanos Medical buyer in Q1 2022 was Goldman Sachs, an estimated $12.7M added.
- The largest Avanos Medical seller in Q1 2022 was Champlain Investment Partners, an estimated $40.7M sold.
Based on aggregated 13F filings for Q1 2022.